Telehealth and Telecare Aware1d
Sycamore Partners taking on 83% debt in financing their Walgreens leveraged buyout–some observations
An analysis cited in HealthExec of the Walgreens buy from the SEC 8-K filing indicates that Sycamore Partners’ offer is a near-classic leveraged buyout, with Sycamore taking on much more debt than ...
Telehealth and Telecare Aware2d
Update: Wojcicki increases 23andMe per share offer to $2.94 from $0.41–but there’s three contingency ‘catches’, and more
The original $0.41 cash for current outstanding shares not owned by Ms. Wojcicki (or not rolled over by current shareholders) Plus three contingent value rights (CVRs) representing the potential ...
Opinion
Telehealth and Telecare Aware3dOpinion
Perspectives: How the DEA Telehealth Extension Impacts Patient Access to Opioid Use Disorder Treatments & Buprenorphine Prescriptions
It wasn’t too long ago when buprenorphine prescribers had their hands tied, with regulations like the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, a previous DEA-enforced statute that ...
Telehealth and Telecare Aware3d
The $10 billion Walgreens take-private deal with Sycamore: what you need to know
Walgreens was too big to fail entirely–but made too many mistakes and remained in too many dying segments. The Gimlet Eye credits Walgreens for making a good deal with private equity firm Sycamore ...